SUM102PT - Cell Line (ID:51120)
HMS LINCS ID: | 51120 |
Name: | SUM102PT |
Alternative Names: | SUM-102PT |
LINCS ID: | |
Alternative ID: | |
Parent Cell Line: | |
Reference Source: | Asterand SUM-102PT |
Organism: | Homo sapiens |
Organ: | breast |
Tissue: | |
Cell Type: | |
Details of Cell Type: | |
Donor Sex: | |
Donor Age: | |
Donor Ethnicity: | |
Donor Health Status: | |
Disease: | DOID:3005, invasive ductal carcinoma |
Details of Disease: | breast ductal adenocarcinoma |
Production Details: | From Asterand: developed from a patient with minimally invasive, ER negative and PR negative human breast carcinoma. |
Genetic Modification(s): | none |
Known Mutations: | |
Citation Information for Mutations: | |
Verification Reference Profile: | |
Growth Properties: | adherent |
Recommended Culture Conditions: | From Asterand: Ham’s F-12 + 1 g/L bovine serum albumin (fatty acid-free), 10 ng/mL EGF, 5 mM ethanolamine, 10 mM HEPES, 1 ug/mL hydrocortisone, 5 ug/mL insulin, 50 nM sodium selenite, 5 ug/mL apo-transferrin, 10 nM triiodo-L-thyronine |
Relevant Citations: | PMID 10604729 |
Usage Note: | |
Comments: | |
Date Publicly Available: | 2016-08-24 |
Most Recent Update: | 2016-08-24 |
Batch Information for HMSL51120-1:
HMS LINCS Batch ID: | 51120-1 |
Provider: | Stephen Ethier (Wayne State University and University of Michigan Medical School) |
Provider Catalog ID: | |
Provider Batch ID: | |
Source Information: | Obtained by Joe Gray's group (Oregon Health & Science University) from Stephen Ethier |
Date Received: | |
HMS QC Outcome: | |
Transient Modification(s): | |
Comments: | |
Date Publicly Available: | 2016-08-24 |
Most Recent Update: | 2016-08-24 |